Pharmacologic adjunctive therapy for acute myocardial infarction.
Thrombolysis and PTCA offer reperfusion for limiting infarct size and reducing mortality in acute myocardial infarction patients. Heparin, aspirin, nitrates, beta-blockers and calcium antagonists are very important in supplementing these two primary reperfusion modes. The adjunctive role of these five pharmacologic agents is discussed.
St Frances Cabrini Hospital, Alexandria, LA.
J W
JW
Landreneau
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000628:therapy; D005996:Nitroglycerin / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D006493:Heparin; D005996:Nitroglycerin; D001241:Aspirin